Cargando…
New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental Confirmation
In the modern world, complications caused by disorders in the blood coagulation system are found in almost all areas of medicine. Thus, the development of new, more advanced drugs that can prevent pathological conditions without disrupting normal hemostasis is an urgent task. The blood coagulation f...
Autores principales: | Tashchilova, Anna, Podoplelova, Nadezhda, Sulimov, Alexey, Kutov, Danil, Ilin, Ivan, Panteleev, Mikhail, Shikhaliev, Khidmet, Medvedeva, Svetlana, Novichikhina, Nadezhda, Potapov, Andrey, Sulimov, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876603/ https://www.ncbi.nlm.nih.gov/pubmed/35209023 http://dx.doi.org/10.3390/molecules27041234 |
Ejemplares similares
-
Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-ij]Quinolin-2(1H)-one as New Inhibitors of Factor Xa and Factor XIa
por: Novichikhina, Nadezhda, et al.
Publicado: (2020) -
Supercomputer Search for the New Inhibitors of the Coagulation Factor XIIa
por: Sulimov, A. V., et al.
Publicado: (2022) -
New Hybrid Tetrahydropyrrolo[3,2,1-ij]quinolin-1-ylidene-2-thioxothiazolidin-4-ones as New Inhibitors of Factor Xa and Factor XIa: Design, Synthesis, and In Silico and Experimental Evaluation
por: Novichikhina, Nadezhda P., et al.
Publicado: (2023) -
New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture
por: Sulimov, Alexey, et al.
Publicado: (2022) -
Quantum-Chemical Quasi-Docking for Molecular Dynamics Calculations
por: Sulimov, Alexey, et al.
Publicado: (2022)